Aptevo Therapeutics Inc (APVO) — Cash Flow Quality Index
Aptevo Therapeutics Inc (APVO) has a Cash Flow Quality Index of 1.65x as of March 2023. Operating cash flow of $4.57 Million exceeds net income of $2.77 Million, indicating high earnings quality where cash backs reported profits. Explore APVO cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aptevo Therapeutics Inc Cash Flow Quality Index (2017–2022)
Historical Cash Flow Quality Index for Aptevo Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Aptevo Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Aptevo Therapeutics Inc (2017–2022)
Year-by-year earnings quality comparison for Aptevo Therapeutics Inc. For live market cap and the full company financial profile, see APVO market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -2.62x | $-21.02 Million | $8.03 Million | ▲ +56.1% |
| 2017 | -5.96x | $-41.57 Million | $6.97 Million | — |